Mestranol was discovered in 1956 and was introduced for medical use in 1957. It was the estrogen component in the first birth control pill. In 1969, mestranol was replaced by ethinylestradiol in most birth control pills, although mestranol continues to be used in a few birth control pills even today. Mestranol remains available only in a few countries, including the United States, United Kingdom, Japan, and Chile.
Our goal is to meet the current needs of patients and caregivers by continually developing our diverse portfolio of products and solutions, and we strive to anticipate future patient needs by evolving through research and development through key therapeutic areas, business development, and innovation.
By building on our strong global presence and harnessing our size and scale, we are increasing access to quality health solutions with the potential to help millions of people around the world. We do this by striving to develop and produce affordable, high-quality generic drugs, innovative specialty pharmaceuticals, and active pharmaceutical ingredients.